Mapping Violence: A Spatial Durbin Analysis of Social Disorganization and Land Use in Houston
Crime & Delinquency · 2026-07 · 72 (8) · 2149-2184
DOI: 10.1177/00111287251391199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crime & Delinquency, online erschienen am 21.11.2025. Verfasst von Kyle D. Maksuta und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
This study examines how social disorganization and land use shape violent crime within and across neighborhoods in Houston, Texas. Using incident-level NIBRS data aggregated to 710 census tracts (2020–2022), we apply a Spatial Durbin Model (SDM) to assess both local and spillover effects. Results show that concentrated disadvantage and racial composition significantly predict violence, with effects extending beyond tract boundaries. Vacant land and entertainment parcels elevate risks in adjacent tracts, while mixed-use development and medical access diffuse protective effects into surrounding areas. By integrating social disorganization and environmental criminology perspectives, findings demonstrate that neighborhood violence is embedded in broader spatial systems and underscore the utility of SDMs for disentangling direct and indirect pathways of urban crime.
Zitieren
APA
Maksuta, K. D., & Zhao, Y. (2026). Mapping Violence: A Spatial Durbin Analysis of Social Disorganization and Land Use in Houston. Crime & Delinquency, 72(8), 2149-2184. https://doi.org/10.1177/00111287251391199
Vancouver
Maksuta KD, Zhao Y. Mapping Violence: A Spatial Durbin Analysis of Social Disorganization and Land Use in Houston. Crime & Delinquency. 2026;72(8):2149-2184. doi:10.1177/00111287251391199
BibTeX
@article{Maksuta2026,
author = {Maksuta, Kyle D. and Zhao, Yunhan},
title = {Mapping Violence: A Spatial Durbin Analysis of Social Disorganization and Land Use in Houston},
journal = {Crime & Delinquency},
year = {2026},
volume = {72},
number = {8},
pages = {2149--2184},
doi = {10.1177/00111287251391199}
}
EUVIMED